These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15163445)

  • 1. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
    Kellner M; Otte C; Yassouridis A; Schick M; Jahn H; Wiedemann K
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):337-9. PubMed ID: 15163445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metyrapone tests in patients with panic disorder.
    Kellner M; Schick M; Yassouridis A; Struttmann T; Wiedemann K; Alm B
    Biol Psychiatry; 2004 Dec; 56(11):898-900. PubMed ID: 15576069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
    Golier JA; Schmeidler J; Yehuda R
    Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.
    de Kloet CS; Vermetten E; Heijnen CJ; Geuze E; Lentjes EG; Westenberg HG
    Psychoneuroendocrinology; 2007 Apr; 32(3):215-26. PubMed ID: 17296270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder.
    Kanter ED; Wilkinson CW; Radant AD; Petrie EC; Dobie DJ; McFall ME; Peskind ER; Raskind MA
    Biol Psychiatry; 2001 Aug; 50(4):238-45. PubMed ID: 11522257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Richards A; Madden E; Rao MN; O'Donovan A; Talbot LS; Rucker E; Metzler TJ; Hauger RL; Neylan TC
    Psychopharmacology (Berl); 2014 Sep; 231(17):3581-95. PubMed ID: 24952092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted ACTH response to dexamethasone suppression-CRH stimulation in posttraumatic stress disorder.
    Ströhle A; Scheel M; Modell S; Holsboer F
    J Psychiatr Res; 2008 Oct; 42(14):1185-8. PubMed ID: 18342888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder.
    Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
    Biol Psychiatry; 2007 Apr; 61(8):952-6. PubMed ID: 17336940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metyrapone test in manic patients and healthy subjects.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    Pharmacopsychiatry; 1984 May; 17(3):94-7. PubMed ID: 6739539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma.
    Santa Ana EJ; Saladin ME; Back SE; Waldrop AE; Spratt EG; McRae AL; LaRowe SD; Timmerman MA; Upadhyaya H; Brady KT
    Psychoneuroendocrinology; 2006 May; 31(4):501-9. PubMed ID: 16413134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age effects on cortisol levels in depressed patients with and without comorbid post-traumatic stress disorder, and healthy volunteers.
    Sher L; Oquendo MA; Galfalvy HC; Cooper TB; Mann JJ
    J Affect Disord; 2004 Oct; 82(1):53-9. PubMed ID: 15465576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
    Yehuda R; Levengood RA; Schmeidler J; Wilson S; Guo LS; Gerber D
    Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased adrenocorticotropin suppression after dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder.
    Duval F; Crocq MA; Guillon MS; Mokrani MC; Monreal J; Bailey P; Macher JP
    Ann N Y Acad Sci; 2004 Dec; 1032():273-5. PubMed ID: 15677426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.